IFM Investors Pty Ltd Increases Stake in Mettler-Toledo International, Inc. (NYSE:MTD)

IFM Investors Pty Ltd increased its position in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 7.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,274 shares of the medical instruments supplier's stock after buying an additional 280 shares during the quarter. IFM Investors Pty Ltd's holdings in Mettler-Toledo International were worth $5,047,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently made changes to their positions in the company. Jones Financial Companies Lllp increased its stake in shares of Mettler-Toledo International by 54.9% during the fourth quarter. Jones Financial Companies Lllp now owns 175 shares of the medical instruments supplier's stock valued at $214,000 after buying an additional 62 shares during the period. SBI Securities Co. Ltd. purchased a new position in shares of Mettler-Toledo International during the fourth quarter valued at approximately $33,000. Steward Partners Investment Advisory LLC increased its position in Mettler-Toledo International by 3.0% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 306 shares of the medical instruments supplier's stock valued at $374,000 after purchasing an additional 9 shares during the period. Keybank National Association OH increased its position in Mettler-Toledo International by 26.2% during the 4th quarter. Keybank National Association OH now owns 636 shares of the medical instruments supplier's stock valued at $778,000 after purchasing an additional 132 shares during the period. Finally, Assetmark Inc. increased its position in Mettler-Toledo International by 40.3% during the 4th quarter. Assetmark Inc. now owns 613 shares of the medical instruments supplier's stock valued at $750,000 after purchasing an additional 176 shares during the period. 95.07% of the stock is owned by hedge funds and other institutional investors.

Mettler-Toledo International Trading Up 0.3%

NYSE MTD opened at $1,209.08 on Monday. Mettler-Toledo International, Inc. has a 12 month low of $946.69 and a 12 month high of $1,546.93. The stock has a market cap of $25.12 billion, a P/E ratio of 30.15, a P/E/G ratio of 3.72 and a beta of 1.37. The stock's fifty day moving average price is $1,150.84 and its 200-day moving average price is $1,195.82.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $8.19 EPS for the quarter, beating the consensus estimate of $7.90 by $0.29. Mettler-Toledo International had a net margin of 22.17% and a negative return on equity of 556.22%. The company had revenue of $883.74 million for the quarter, compared to the consensus estimate of $876.61 million. During the same period in the prior year, the firm posted $8.89 EPS. Mettler-Toledo International's revenue for the quarter was down 4.6% on a year-over-year basis. As a group, analysts forecast that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Mettler-Toledo International news, Director Michael A. Kelly sold 1,062 shares of the stock in a transaction on Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total transaction of $1,231,845.66. Following the sale, the director directly owned 120 shares in the company, valued at approximately $139,191.60. This trade represents a 89.85% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.77% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on MTD shares. UBS Group upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and reduced their price target for the company from $1,530.00 to $1,350.00 in a research report on Tuesday, May 20th. Jefferies Financial Group upgraded Mettler-Toledo International from an "underperform" rating to a "hold" rating and reduced their target price for the stock from $1,200.00 to $1,110.00 in a report on Monday, May 5th. Barclays initiated coverage on Mettler-Toledo International in a report on Tuesday, June 24th. They set an "overweight" rating and a $1,325.00 target price on the stock. Wells Fargo & Company upped their price target on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a research note on Monday, May 5th. Finally, Wall Street Zen cut Mettler-Toledo International from a "buy" rating to a "hold" rating in a research note on Monday, May 5th. Eight analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $1,300.36.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.